(Q37731322)

22 August 2017

1 reference

title

Progress in epidermolysis bullosa research: toward treatment and cure (English)

1 reference

22 August 2017

main subject

epidermolysis bullosa

1 reference

1

Jouni Uitto

1 reference

22 August 2017

Leena Bruckner-Tuderman

series ordinal

4

object named as

Leena Bruckner-Tuderman

1 reference

22 August 2017

John A McGrath

2

1 reference

22 August 2017

Ulrich Rodeck

series ordinal

3

1 reference

22 August 2017

E Clare Robinson

series ordinal

5

1 reference

22 August 2017

language of work or name

English

0 references

publication date

15 April 2010

1 reference

Journal of Investigative Dermatology

22 August 2017

published in

1 reference

22 August 2017

volume

130

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

1778-1784

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2010.90

22 August 2017

exact match

0 references

cites work

Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Growth factors and cytokines in wound healing

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Peripheral blood mononuclear cell subsets in patients with severe inherited forms of epidermolysis bullosa

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

IL-23 promotes tumour incidence and growth

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Tumor necrosis factor antagonists in the therapy of psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Cryopyrinopathies: update on pathogenesis and treatment.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Molecular therapies for heritable blistering diseases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Advocacy groups as research organizations: the PXE International example

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Altered expression of L-arginine metabolism pathway genes in chronic wounds in recessive dystrophic epidermolysis bullosa.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

A new approach for the prophylactic improvement of surgical scarring: avotermin (TGF beta 3).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2010.90

7 January 2021

Identifiers

DOI

10.1038/JID.2010.90

1 reference

22 August 2017

1 reference